维普中文期刊产品整合服务
792篇 您的检索式:作者名="Waki"
    题名 作者 年代 出处 被引量
1女贞种子和幼苗对模拟酸雨的反应显示文摘将女贞种子和 1年生幼苗置于不同pH值的模拟酸雨条件下观测和分析其形态和生理变化。结果表明 ,不同处理间女贞种子发芽率无统计上的显著差异 ,但 pH2 .0和pH3 .5的模拟酸雨对种子发芽显示了一定的抑制作用。在pH2 .0的模拟酸雨条件下 ,女贞幼苗叶片表现明显的受害症状 ,叶绿素含量下降 ,细胞透性增加 ,叶汁液酸化 ,从而使幼苗生长严重受阻。在 pH3 .5的处理下幼苗没有表现明显的形态和生理变化 ,但生长量呈现下降趋势 ,而 pH5.0的处理对幼苗地上部分生长产生一定的促进作用。pH6.樊后保 臧润国 Kosuke Waki 2000林业科学2000,36,6:37
2Refractory gastric ulcer with abundant IgG4-positive plasma cell infiltration: A case report显示文摘We describe a 77-year-old man with refractory gastric ulcer that worsened after Helicobacter pylori eradication therapy.Pathology showed marked infiltration of IgG4-positive plasma cells in the gastric lesions,which led us to suspect IgG4-related sclerosing disease.To the best of our knowledge,this is the first report of IgG4-related gastric ulcer without the main manifestation of autoimmune pancreatitis.Takayoshi Fujita Takafumi Ando Masatoshi Sakakibara Waki Hosoda Hidemi Goto 2010World Journal of Gastroenterology2010,16,17:13
3Prognostic value of K - ras mutation status and subtypes in endoscopic ultrasound-guided fine-needle aspiration specimens from patients with unresectable pancreatic cancer显示文摘Takeshi Ogura Kenji Yamao Kazuo Hara Nobumasa Mizuno Susumu Hijioka Hiroshi Imaoka Akira Sawaki Yasumasa Niwa Masahiro Tajika Shinya Kondo Tsutomu Tanaka Yasuhiro Shimizu Vikram Bhatia Kazuhide Higuchi Waki Hosoda Yasushi Yatabe 2013Journal of Gastroenterology2013,,5:4
4Can EUS-guided FNA distinguish between gallbladder cancer and xanthogranulomatous cholecystitis?显示文摘Susumu Hijioka Mohamed A. Mekky Vikram Bhatia Akira Sawaki Nobumasa Mizuno Kazuo Hara Waki Hosoda Yasuhiro Shimizu Kiichi Tamada Yasumasa Niwa Kenji Yamao 2010Gastrointestinal Endoscopy2010,,3:3
5Effects of a 24-week course of interferon-αtherapy after curative treatment of hepatitis C virus-associated hepatocellular carcinoma显示文摘AIM:To assess whether a 24-wk course of interferon (IFN)could prevent hepatocellular carcinoma(HCC) recurrence and worsening of liver function in patients with hepatitis C virus(HCV)-infected patients after receiving curative treatment for primary HCC. METHODS:Outcomes in 42 patients with HCV infection treated with IFN-α,after curative treatment for primary HCC(IFN group),were compared with 42 matched curatively treated historical controls not given IFN(non- IFN group). RESULTS:Although the rate of initial recurrence did not differ significantly between IFN group and non-IFN group (0%,44%,61%,and 67% vs 4.8%,53%,81%,and 87% at 1,3,5,and 7 years,P=0.153,respectively), IFN group showed a lower rate than the non-IFN group for second recurrence(0%,10.4%,28%,and 35% vs 0%,30%,59%,and 66% at 1,3,5 and 7 years, P=0.022,respectively).Among the IFN group,patients with sustained virologic response(SVR)were less likely to have a second HCC recurrence than IFN patients without an SVR,or non-IFN patients.Multivariate analysis identified the lack of SVR as the only independent risk factor for a second recurrence,while SVR and Child-Pugh class A independently favored overall survival. CONCLUSION:Most intrahepatic recurrences of HCV- related HCC occurred during persistent viral infection. Eradication of HCV is essential for the prevention of HCC recurrence and improvement of survival.Soo Cheol Jeong Hiroshi Aikata Yoshio Katamura Takahiro Azakami Tomokazu Kawaoka Hiromi Saneto Kiminori Uka Nami Mori Shintaro Takaki Hideaki Kodama Koji Waki Michio Imamura Hiroo Shirakawa Yoshiiku Kawakami Shoichi Takahashi Kazuaki Chayama 2007World Journal of Gastroenterology2007,13,40:3
6Low-dose intermittent interferon-alpha therapy for HCV-related liver cirrhosis after curative treatment of hepatocellular carcinoma显示文摘AIM: To assess the efficacy of low-dose intermittent interferon (IFN) therapy in patients with hepatitis C virus (HCV)-related compensated cirrhosis who had received curative treatment for primary hepatocellular carcinoma (HCC). METHODS: We performed a prospective case controlled study. Sixteen patients received 3 MIU of natural IFN- alpha intramuscularly 3 times weekly for at least 48 wk (IFN group). They were compared with 16 matched historical controls (non-IFN group). RESULTS: The cumulative rate of first recurrence of HCC was not significantly different between the IFN group and the non-IFN group (0% vs 6.7% and 68.6% vs 80% at 1- and 3-year, P = 0.157, respectively). The cumulative rate of second recurrence was not also significantly different between the IFN group and the non-IFN group (0% vs 6.7% and 35.9% vs 67% at 1- and 3-year, P = 0.056, respectively). Although the difference in the Child-Pugh classification score between the groups at initial treatment of HCC was not signifi cant, the score was signifi cantly worse at the time of data analysis in the non-IFN group than IFN group (7.19 ± 1.42 vs 5.81 ± 0.75, P = 0.0008). The cumulative rate of deviation from objects of any treatment for recurrentHCC was also higher in the non-IFN group than IFN group (6.7% and 27% vs 0 and 0% at 1- and 3-year, P = 0.048, respectively). CONCLUSION: Low-dose intermittent IFN-alpha therapy for patients with HCV-related compensated cirrhosis after curative HCC treatment was effective by making patients tolerant to medical or surgical treatment for recurrent HCC in the later period of observation.Soocheol Jeong Hiroshi Aikata Yoshio Katamura Takahiro Azakami Tomokazu Kawaoka Hiromi Saneto Kiminori Uka Nami Mori Shintaro Takaki Hideaki Kodama Koji Waki Michio Imamura Hiroo Shirakawa Yoshiiku Kawakami Shoichi Takahashi Kazuaki Chayama 2007World Journal of Gastroenterology2007,13,39:2
7The fat derived hormone adiponectin reverses insulin resistance with both lipoatrophy and obesity显示文摘Yamauchi T Kamon J Waki H 2001Nat Med2001,7,8:2
8Intra-arterial 5-fluorouracil/interferon combination therapy for advanced hepatocellular carcinoma with or without three-dimensional conformal radiotherapy for portal vein tumor thrombosis显示文摘Yoshio Katamura Hiroshi Aikata Shintaro Takaki Takahiro Azakami Tomokazu Kawaoka Koji Waki Akira Hiramatsu Yoshiiku Kawakami Shoichi Takahashi Masahiro Kenjo Naoyuki Toyota Katsuhide Ito Kazuaki Chayama 2009Journal of Gastroenterology2009,,5:2
9The fat derived hormone adiponectin reverses insulin resistance associated with both lipoatmphy and obesity显示文摘 Kamon J Waki H 2001Nat Med2001,7,8:1
10Micro determination of Chromium,iron,copper and cobalt in water显示文摘Yoshimura K Waki H Ohashi S 1976Talanta1976,23,:1
11Hypersensitivity Reactions to Transcatheter Chemoembolization with Cisplatin and Lipiodol Suspension for Unresectable Hepatocellular Carcinoma显示文摘Tomokazu Kawaoka Hiroshi Aikata Yoshio Katamura Shintaro Takaki Koji Waki Akira Hiramatsu Shoichi Takahashi Masashi Hieda Hideaki Kakizawa Kazuaki Chayama 2010Journal of Vascular and Interventional Radiology2010,,8:1
12Thermal deformation and its on-line compensation of hydrostatically supported precision spindle显示文摘MOR/WAKI T 1988Manufacturing Technology1988,37,1:1
13The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity显示文摘Yamauchi T Kamon J Waki H 2001Nature Medicine2001,7,8:1
14Liver tumor promotion by the cyanobacterial cyclic peptide toxin microcystin-LR显示文摘NISHIWAKI-MATSUSHIMA R OHTAT NISH/WAKI S 1992Cancer Res Clin Onco11992,118,:1
15The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity 显示文摘Yamauchi T Kamon J Waki H 2001Nat Med2001,7,:1
16Effects of pharmacologic agents on human keloids implanted in athymic mice 显示文摘Waki EY 1991Arch Otolaryngol Head Neck Surg1991,117,10:1
17The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity显示文摘Yamauchi T Kamon J Waki H 2001Nat Med2001,7,8:1
18Thermal analysis of ground tire rubber devulcanized by microwaves显示文摘Scuracchio C H Waki D A DaSilva M L C P 2007Journal of Thermal Analysis and Calorimetry2007,87,3:1
19Endocrine functions of adipose tissue显示文摘Waki H Tontonoz P 2007Annu Rev Pathol2007,2,:1
20Inhibition of RXR and PPAR ameliorates diet-induced obesity and type 2 diabetes显示文摘Yamauchi T Waki H Kamon J 2001J Clin Invest2001,108,7:1
返回顶部 每页显示:
共40页 首页 上一页 第1页 下一页 末页 /40 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费